Sulfonylureas in the modern strategy of therapy of type 2 diabetes
Type 2 diabetes mellitus (DM2) is a chronic progressing disease associated with insulin resistance and impaired insulin secretion insufficient toovercome insulin resistance that deteriorates as a result of glucose toxicity and beta-cell apoptosis. Combination of metformin and sulfonylureas (SU) iscu...
Guardado en:
Autor principal: | Lyudmila Viktorovna Nedosugova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a65c44089e3c45739b19f527dab250f0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sulfonylureas and cardiovascular complications of type 2 diabetes mellitus
por: Lyudmila Viktorovna Nedosugova
Publicado: (2013) -
Glibenclamide - profile of efficacy and safety
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011) -
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012) -
Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012) -
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)